Medical registries in perspective of the new EU’s legal framework of personal data protection - selected issues
Journal Title: JOURNAL OF HEALTH POLICY & OUTCOMES RESEARCH - Year 2016, Vol 9, Issue 1
Abstract
Keeping medical registries is inextricably linked with the processing of personal data, which often belong to the most sensitive sphere of privacy of every individual. Creating a comprehensive and complete legislation in this area is a guarantee of proper protection of the privacy and dignity of the patient, and is a part of the optimal model of protection of personal data representing the content of the registers, which is guaranteed both at the level of constitutional and international law. The creation of appropriate legal mechanisms must also be accompanied by a friendly technical and organizational environment. Lack of financial resources to ensure the security of data stored in the medical records may result in the risk of data leaks, unauthorized access to data, or using data for the wrongpurposes. In view of the reform of the EU data protection law the above-mentioned circumstances must be a subject of in-depth analysis.
Authors and Affiliations
Monika Krasińska
Keywords
Related Articles
- EP ID EP192264
- DOI 10.7365/JHPOR.2016.1.1
- Views 65
- Downloads 0
What should we know about the Zika virus?
Zika virus (ZIKV) is a vector-borne arbovirus of the Flaviviridae family, which also includes dengue, West Nile, yellow fever and Japanese encephalitis viruses. It is transmitted by daytime-active Aedes mosquitoes. Simi...
Assessment of quality of life, disease activity and productivity loss of patients with ulcerative colitis in Poland
Purpose: The aim of the study was to assess the relationship between the disease activity and both indirect costs and health-related quality of life among ulcerative colitis (UC) patients in Poland. Methods: A questionn...
Assessment of thrombocytopenia symptoms using vignettes. Preliminary report on the development and implementation of a new instrument
Objective: Our aim was to create a vignette enabling the assessment of the impact of thrombocytopenia symptoms on patients’ quality of life. Methods: The vignettes which we created are focused on thrombocytopenia sym...
Neoadjuvant treatment of HER2-positive breast cancer – pathological complete response (pCR) as a surrogate of long term outcomes in the context of regulatory guidelines and reimbursement recommendations.
Background: The vast heterogeneity of breast cancer (BC) patients, together with relatively long survival in the early stages of the disease, leads to methodological issues in designing clinical trials, particularly in c...
The combination of angiotensin converting enzyme inhibitors, diuretics and non-steroidal anti-inflammatory drugs in the routine community pharmacy settings in Poland: The unrecognized problem of ‘Triple Whammy’. A pilot analysis.
Background: ‘Triple Whammy’ defined as a combination of angiotensin converting enzyme inhibitors/angiotensin receptor antagonist, diuretics and non-steroidal anti-inflammatory drugs remains an important clinical problem,...